Association of Summed Rest Score on Technetium‐99m Sestamibi With Exercise Capacity and Incident Adverse Outcomes in Hospitalized Patients With Nonischemic Cardiomyopathy: A Retrospective Analysis
Open Access
- 1 September 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (17)
Abstract
Background: In nonischemic cardiomyopathy, the clinical relevance of decreased resting myocardial technetium‐99m sestamibi ( 99m Tc‐MIBI) uptake regarding exercise capacity and clinical outcomes remains incompletely understood. We investigated whether decreased 99m Tc‐MIBI uptake is associated with impaired exercise capacity and adverse clinical outcomes in nonischemic cardiomyopathy. Methods: We retrospectively analyzed 182 patients (mean age 51.4±14.0 years; 27% female) with nonischemic cardiomyopathy and left ventricular ejection fraction 99m Tc‐MIBI scintigraphy and cardiopulmonary exercise testing from 2016 to 2023. Myocardial uptake of 99m Tc‐MIBI was evaluated using the summed rest score (SRS). Exercise capacity was assessed by percentage of predicted peak oxygen consumption (PPVO 2 ), with ≤60% defining impairment. Results: Seventy‐four patients (41%) had PPVO 2 ≤60% and higher SRS (median: 12 versus 8; P < 0.001). Higher SRS remained significantly associated with PPVO 2 ≤60% after adjustment for relevant clinical covariates, including brain natriuretic peptide level, left ventricular ejection fraction, and heart failure duration. Over a median follow‐up of 807 days, 23 patients (13%) experienced the composite outcome of all‐cause death, ventricular assist device implantation, or heart transplantation. Higher SRS was associated with composite outcomes after adjusting for PPVO 2 ≤60%. Among the 4 groups stratified by median SRS of 9 and PPVO 2 of 60%, patients with high SRS and low PPVO 2 had the highest incidence of adverse events. Conclusions: Decreased myocardial 99m Tc‐MIBI uptake was associated with impaired exercise capacity and adverse outcomes in patients with nonischemic cardiomyopathy. Our findings suggest that myocardial injury assessment using 99m Tc‐MIBI scintigraphy may provide prognostic information complementary to exercise capacity.Keywords
This publication has 26 references indexed in Scilit:
- A Scoring Evaluation for the Practical Introduction of Guideline-Directed Medical Therapy in Heart Failure PatientsESC Heart Failure, 2023
- Focal severe decrease in myocardial technetium-99 m sestamibi uptake indicates ventricular irreversibility in patients with dilated cardiomyopathyAnnals of Nuclear Medicine, 2021
- Impact of myocardial perfusion abnormality on prognosis in patients with non-ischemic dilated cardiomyopathyJournal of Cardiology, 2010
- Comparison of Global and Regional Abnormalities in 99mTc-sestamibi and Cardiac Magnetic Resonance Imaging in Dilated CardiomyopathyJournal of Cardiac Failure, 2010
- Prediction of New-Onset Refractory Congestive Heart Failure Using Gated Myocardial Perfusion SPECT Imaging in Patients With Known or Suspected Coronary Artery DiseaseJACC: Cardiovascular Imaging, 2009
- Myocardial perfusion, function, and dyssynchrony in patients with heart failure: Baseline results from the single-photon emission computed tomography imaging ancillary study of the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) TrialAmerican Heart Journal, 2009
- Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-ACCESS studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2007
- Relevance of Coronary Microvascular Flow Impairment to Long-Term Remodeling and Systolic Dysfunction in Hypertrophic CardiomyopathyJACC, 2006
- Prognostic value of thallium-201 perfusion defects in idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1991
- Correlates and prognostic implication of exercise capacity in chronic congestive heart failureThe American Journal of Cardiology, 1985